Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Глобальная эпидемиология, бремя для здоровья и эффективные вмешательства при повышенном артериальном давлении и гипертензии
2021-05-28
SCID: 54.1/c6kfbhus
Discuss with AI
elevated blood pressureglobal epidemiologyhypertension prevalencehypertension treatment coveragepopulation-level dietary interventions
Figures from the paper
Abstract (AI)
High blood pressure is one of the most important risk factors for ischaemic heart disease, stroke, other cardiovascular diseases, chronic kidney disease and dementia. Mean blood pressure and the prevalence of raised blood pressure have declined substantially in high-income regions since at least the 1970s. By contrast, blood pressure has risen in East, South and Southeast Asia, Oceania and sub-Saharan Africa. Given these trends, the prevalence of hypertension is now higher in low-income and middle-income countries than in high-income countries. In 2015, an estimated 8.5 million deaths were attributable to systolic blood pressure >115 mmHg, 88% of which were in low-income and middle-income countries. Measures such as increasing the availability and affordability of fresh fruits and vegetables, lowering the sodium content of packaged and prepared food and staples such as bread, and improving the availability of dietary salt substitutes can help lower blood pressure in the entire population. The use and effectiveness of hypertension treatment vary substantially across countries. Factors influencing this variation include a country's financial resources, the extent of health insurance and health facilities, how frequently people interact with physicians and non-physician health personnel, whether a clear and widely adopted clinical guideline exists and the availability of medicines. Scaling up treatment coverage and improving its community effectiveness can substantially reduce the health burden of hypertension.
Key Findings
1
Blood pressure has risen in East, South and Southeast Asia, Oceania and sub-Saharan Africa, making hypertension now more prevalent in low- and middle-income countries than in high-income countries.
2
In 2015, an estimated 8.5 million deaths were attributable to systolic blood pressure >115 mmHg, with 88% of these deaths occurring in low- and middle-income countries.
3
Mean blood pressure and prevalence of raised blood pressure have declined substantially in high-income regions since at least the 1970s.
4
Population-level measures—greater availability and affordability of fresh fruits and vegetables, reduced sodium in packaged/prepared foods and staples, and wider use of dietary salt substitutes—can help lower blood pressure across populations.
5
Treatment use and effectiveness for hypertension vary substantially across countries due to resources, health insurance and facilities, frequency of health worker interactions, presence of clinical guidelines, and medicine availability; scaling up coverage and community effectiveness can substantially reduce hypertension burden.
Research Object
Elevated blood pressure and hypertension at the global population level
Research Subject
Global epidemiology, health burden (mortality and disease burden) and effectiveness of population-level interventions and treatment scale-up to reduce elevated blood pressure and hypertension
Publication Details
Publication Date
2021-05-28
Journal
Publisher
ISSN
Cited by
1551
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai8
2018 ESC/ESH Guidelines for the management of arterial hypertension2018
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines2017
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20152016
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172018
2020 International Society of Hypertension Global Hypertension Practice Guidelines2020
A century of trends in adult human height2016
Cardiovascular effects of environmental noise exposure2014
Cited by2
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants2021
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension2023